ImmuCell Cash And Cash Equivalents Changes vs End Period Cash Flow Analysis

ICCC Stock  USD 3.72  0.02  0.54%   
ImmuCell financial indicator trend analysis is infinitely more than just investigating ImmuCell recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ImmuCell is a good investment. Please check the relationship between ImmuCell Cash And Cash Equivalents Changes and its End Period Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuCell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade ImmuCell Stock refer to our How to Trade ImmuCell Stock guide.

Cash And Cash Equivalents Changes vs End Period Cash Flow

Cash And Cash Equivalents Changes vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ImmuCell Cash And Cash Equivalents Changes account and End Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between ImmuCell's Cash And Cash Equivalents Changes and End Period Cash Flow is 0.42. Overlapping area represents the amount of variation of Cash And Cash Equivalents Changes that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of ImmuCell, assuming nothing else is changed. The correlation between historical values of ImmuCell's Cash And Cash Equivalents Changes and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Cash Equivalents Changes of ImmuCell are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Cash And Cash Equivalents Changes i.e., ImmuCell's Cash And Cash Equivalents Changes and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.42
Relationship DirectionPositive 
Relationship StrengthWeak

Cash And Cash Equivalents Changes

End Period Cash Flow

Most indicators from ImmuCell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmuCell current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuCell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade ImmuCell Stock refer to our How to Trade ImmuCell Stock guide.At present, ImmuCell's Enterprise Value is projected to increase significantly based on the last few years of reporting.
 2021 2022 2023 2024 (projected)
Gross Profit8.7M7.6M4.4M3.9M
Total Revenue19.2M18.6M17.5M18.3M

ImmuCell fundamental ratios Correlations

0.940.850.910.980.980.63-0.610.560.98-0.060.170.950.880.940.75-0.320.980.940.660.820.380.610.940.870.9
0.940.940.960.840.960.85-0.790.260.960.09-0.150.890.751.00.88-0.240.941.00.420.920.210.510.980.760.79
0.850.940.920.740.860.83-0.890.180.850.29-0.190.830.680.930.93-0.080.90.940.420.880.040.410.960.670.73
0.910.960.920.820.920.83-0.790.230.920.11-0.120.870.70.950.91-0.210.930.970.460.930.280.630.960.730.77
0.980.840.740.820.940.45-0.460.720.93-0.150.360.920.910.850.62-0.360.950.850.770.70.450.610.850.90.9
0.980.960.860.920.940.71-0.640.461.0-0.020.020.920.840.970.75-0.280.960.960.530.850.390.570.940.850.87
0.630.850.830.830.450.71-0.83-0.280.710.24-0.580.580.370.840.88-0.110.650.85-0.020.84-0.030.340.810.40.45
-0.61-0.79-0.89-0.79-0.46-0.64-0.830.07-0.63-0.430.43-0.63-0.45-0.77-0.89-0.14-0.72-0.78-0.17-0.850.14-0.19-0.81-0.47-0.53
0.560.260.180.230.720.46-0.280.070.46-0.270.810.560.70.28-0.01-0.230.540.270.830.140.460.310.310.670.64
0.980.960.850.920.931.00.71-0.630.46-0.040.020.920.840.970.75-0.30.960.960.520.850.380.570.940.840.86
-0.060.090.290.11-0.15-0.020.24-0.43-0.27-0.04-0.42-0.1-0.070.080.250.660.030.09-0.160.2-0.05-0.140.13-0.07-0.03
0.17-0.15-0.19-0.120.360.02-0.580.430.810.02-0.420.180.34-0.13-0.28-0.350.13-0.130.76-0.260.280.21-0.110.30.26
0.950.890.830.870.920.920.58-0.630.560.92-0.10.180.830.890.71-0.30.950.890.650.780.270.560.920.810.85
0.880.750.680.70.910.840.37-0.450.70.84-0.070.340.830.760.54-0.280.870.750.80.660.350.440.760.990.98
0.941.00.930.950.850.970.84-0.770.280.970.08-0.130.890.760.87-0.240.941.00.440.90.230.530.980.770.8
0.750.880.930.910.620.750.88-0.89-0.010.750.25-0.280.710.540.87-0.170.80.880.330.87-0.050.440.90.540.61
-0.32-0.24-0.08-0.21-0.36-0.28-0.11-0.14-0.23-0.30.66-0.35-0.3-0.28-0.24-0.17-0.23-0.24-0.3-0.170.21-0.1-0.19-0.22-0.21
0.980.940.90.930.950.960.65-0.720.540.960.030.130.950.870.940.8-0.230.950.660.860.30.550.960.860.89
0.941.00.940.970.850.960.85-0.780.270.960.09-0.130.890.751.00.88-0.240.950.450.910.240.550.980.760.8
0.660.420.420.460.770.53-0.02-0.170.830.52-0.160.760.650.80.440.33-0.30.660.450.310.330.490.490.770.77
0.820.920.880.930.70.850.84-0.850.140.850.2-0.260.780.660.90.87-0.170.860.910.310.110.320.90.680.71
0.380.210.040.280.450.39-0.030.140.460.38-0.050.280.270.350.23-0.050.210.30.240.330.110.710.190.430.39
0.610.510.410.630.610.570.34-0.190.310.57-0.140.210.560.440.530.44-0.10.550.550.490.320.710.530.510.52
0.940.980.960.960.850.940.81-0.810.310.940.13-0.110.920.760.980.9-0.190.960.980.490.90.190.530.760.81
0.870.760.670.730.90.850.4-0.470.670.84-0.070.30.810.990.770.54-0.220.860.760.770.680.430.510.761.0
0.90.790.730.770.90.870.45-0.530.640.86-0.030.260.850.980.80.61-0.210.890.80.770.710.390.520.811.0
Click cells to compare fundamentals

ImmuCell Account Relationship Matchups

ImmuCell fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets38.7M40.4M44.5M44.9M43.8M46.0M
Short Long Term Debt Total8.4M10.7M10.3M12.5M16.7M17.5M
Other Current Liab648.4K747.9K867.1K1.2M1.2M1.3M
Total Current Liabilities2.5M2.2M2.5M3.1M4.2M4.4M
Total Stockholder Equity29.0M28.3M32.6M30.4M25.0M26.2M
Property Plant And Equipment Net25.3M28.0M28.0M30.6M32.1M33.8M
Net Debt(352.5K)2.8M89.0K6.7M15.7M16.5M
Retained Earnings(2.6M)(3.7M)(3.7M)(6.2M)(12.0M)(11.4M)
Cash8.8M7.9M10.2M5.8M978.7K929.8K
Non Current Assets Total25.5M28.2M28.2M30.9M32.3M34.0M
Non Currrent Assets Other26.9K26.2K26.1K76.6K57.7K54.8K
Cash And Short Term Investments8.8M7.9M10.2M5.8M978.7K929.8K
Net Receivables1.7M1.9M2.7M1.8M2.2M2.3M
Common Stock Shares Outstanding6.8M7.2M7.6M7.7M7.7M3.9M
Liabilities And Stockholders Equity38.7M40.4M44.5M44.9M43.8M46.0M
Non Current Liabilities Total7.2M9.9M9.4M11.4M14.6M15.2M
Inventory2.5M2.1M3.1M6.0M7.8M8.2M
Other Current Assets219.1K253.6K268.7K363.9K493.9K247.6K
Other Stockholder Equity30.9M31.2M35.5M35.8M36.2M38.0M
Total Liab9.7M12.1M11.9M14.5M18.8M19.8M
Total Current Assets13.2M12.2M16.3M14.0M11.5M7.0M
Short Term Debt1.3M860.8K920.2K1.1M2.1M2.0M
Intangible Assets114.6K95.5K76.4K57.3K38.2K36.3K
Accounts Payable572.2K602.3K745.0K790.0K874.6K918.3K
Property Plant And Equipment Gross25.3M26.8M42.0M46.5M53.5M56.2M
Other Assets164.0406.0312.0351.01.00.95
Long Term Debt7.1M8.7M8.3M9.2M10.6M11.1M
Treasury Stock(407.9K)(204.9K)(188.3K)(175.4K)(201.7K)(211.8K)
Property Plant Equipment25.3M28.0M28.0M30.6B35.2B37.0B
Net Tangible Assets28.8M27.8M32.3M30.2B34.8B36.5B
Retained Earnings Total Equity979.0K(1.3M)(2.6M)(3.7M)(3.3M)(3.1M)
Long Term Debt Total8.6M8.4M7.1M8.7M10.0M10.6M
Capital Surpluse22.5M22.7M31.1M31.4M36.1M19.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ImmuCell offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImmuCell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immucell Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immucell Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuCell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade ImmuCell Stock refer to our How to Trade ImmuCell Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmuCell. If investors know ImmuCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmuCell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.63)
Earnings Share
(0.49)
Revenue Per Share
2.991
Quarterly Revenue Growth
0.549
Return On Assets
(0.05)
The market value of ImmuCell is measured differently than its book value, which is the value of ImmuCell that is recorded on the company's balance sheet. Investors also form their own opinion of ImmuCell's value that differs from its market value or its book value, called intrinsic value, which is ImmuCell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmuCell's market value can be influenced by many factors that don't directly affect ImmuCell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmuCell's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmuCell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmuCell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.